Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Prattes, J; Schilcher, G; Krause, R.
Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.
Mycoses. 2015; 58(1):4-9
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Krause Robert
Prattes Jürgen
Schilcher Gernot
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
The serum 1,3-beta-D-glucan (BDG) test is a pan-fungal serum marker considered to detect the majority of pathogenic fungi, including Aspergillus spp. and Candida spp. For this review we searched for publications dealing with serum BDG levels in patients undergoing renal replacement therapy (RRT). The influence of various different membrane materials used for RRTs in these publications on serum BDG has been reviewed. We found that unmodified cellulose containing membranes increased the serum BDG levels highly, whereas conflicting results have been observed for modified cellulose containing materials. Synthetic materials (e.g. polysuflone) had no influence on serum BDG levels in the majority of the reviewed publications. © 2014 Blackwell Verlag GmbH.
Find related publications in this database (using NLM MeSH Indexing)
Antigens, Fungal - blood
Biomarkers - blood
Cellulose -
False Positive Reactions -
Female -
Humans -
Male -
Mycoses - diagnosis
Renal Dialysis - instrumentation
Reproducibility of Results -
beta-Glucans - blood

Find related publications in this database (Keywords)
1
3-Beta-d-glucan
renal replacement therapy
© Meduni Graz Impressum